Taiga Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Taiga Biotechnologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10566
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Taiga Biotechnologies Inc (Taiga Biotech) is a biopharmaceutical company that develops protein and cellular therapies. The company develops therapies for diseases including cancers and infectious diseases. It provides pipeline products such as programs such as stem cell therapy and target specific T-cells, among others. Taiga Biotech provides programs are developed for diseases such as HIV and influenza, and hematologic conditions. The company offers technologies for HSCs that offers variety of applications for drug discovery, screening, product development, and others. It conducts research in the clinical areas of red blood cell pharming, vaccine adjuvants cell therapies, bone marrow engraftment enhancer, and others. The company utilizes natural defenses to fight infectious disease and various forms of cancer, including both hematological cancers, solid tumors, and others. Taiga Biotech is headquartered in Aurora, Colorado, the US.

Taiga Biotechnologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Taiga Biotech Raises USD6 Million in Venture Financing 10
Taiga Biotech Raises Additional USD8.8 Million in Financing Round 11
Taiga Biotech Raises USD3 Million in Venture Financing 12
Taiga Biotechnologies Inc – Key Competitors 13
Taiga Biotechnologies Inc – Key Employees 14
Taiga Biotechnologies Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taiga Biotechnologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Taiga Biotech Raises USD6 Million in Venture Financing 10
Taiga Biotech Raises Additional USD8.8 Million in Financing Round 11
Taiga Biotech Raises USD3 Million in Venture Financing 12
Taiga Biotechnologies Inc, Key Competitors 13
Taiga Biotechnologies Inc, Key Employees 14

List of Figures
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taiga Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Taiga Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • Urban One Inc (UONEK):企業の財務・戦略的SWOT分析
    Urban One Inc (UONEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Range Resources Corporation:企業の戦略・SWOT・財務情報
    Range Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Range Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Wolfgang Puck Worldwide, Inc.:企業の戦略・SWOT・財務情報
    Wolfgang Puck Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wolfgang Puck Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務情報
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Kroger Co:戦略・SWOT・企業財務分析
    The Kroger Co - Strategy, SWOT and Corporate Finance Report Summary The Kroger Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancer …
  • Owensboro Municipal Utilities:企業の戦略的SWOT分析
    Owensboro Municipal Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Cox & Kings Limited
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • E.ON SE (EOAN)-石油・ガス分野:企業M&A・提携分析
    Summary E.ON SE (E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports, and supplies gas and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, na …
  • Exact Sciences Corp (EXAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • Galecto Biotech AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Galecto Biotech AB (Galecto Biotech) is a drug development company that focuses on the development of galectin modulators for the treatment of cancer, fibrosis and inflammation. The company develops activators and inhibitors of galectins. Its pipeline products include TD139 inhaled Gal -3 in …
  • W. L. Gore & Associates, Inc.:企業の戦略・SWOT・財務情報
    W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Lanco Infratech Ltd (LITL):電力:M&Aディール及び事業提携情報
    Summary Lanco Infratech Ltd. (Lanco) is an integrated infrastructure enterprise that operates in diversified fields such as engineering, procurement and construction (EPC); operation and maintenance; and development. Through delivery partners in construction, civil, and electrical engineering, it of …
  • Syndicate Bank Ltd (SYNDIBANK):企業の財務・戦略的SWOT分析
    Syndicate Bank Ltd (SYNDIBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • JSP Corp (7942):企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Protective Life Corporation:企業の戦略・SWOT・財務情報
    Protective Life Corporation - Strategy, SWOT and Corporate Finance Report Summary Protective Life Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cryptzone AB:企業の戦略的SWOT分析
    Cryptzone AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Torax Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TORAX Medical Inc (Torax Medical), a subsidiary of Ethicon US LLC, is a healthcare company that offers technology solutions. The company offers LINX reflux management system, a clinical stage medical device. Torax Medical offers treatment for gastro esophageal reflux disease that can turn in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆